Clinical Nurse Specialist in Boca Raton, FL Accepting Medicare
5 Clinical Nurse Specialist nurses found. Showing 1 - 5
 Dr. Jodi Karen Weinstein, A.R.N.P, C.S, PH.D Clinical Nurse Specialist - Psych/Mental Health, Child & Adolescent Medicare: Accepting Medicare Assignments Practice Location: 4700 Nw 2nd Ave Ste 101102, Boca Raton, FL 33431 Phone: 561-563-6262 Fax: 561-223-2974 |
Mariam S. Urdaneta, ARNP, FNP-C Clinical Nurse Specialist - Family Health Medicare: Not Enrolled in Medicare Practice Location: 64 S Federal Hwy, Boca Raton, FL 33432 Phone: 786-515-4559 |
Amelia Schreibman, ARNP Clinical Nurse Specialist - Family Health Medicare: Not Enrolled in Medicare Practice Location: 1601 Clint Moore Rd, 178, Boca Raton, FL 33487 Phone: 561-939-0350 Fax: 561-939-0351 |
Jacqueline Deborah Simon, APRN, PMHNP-BC Clinical Nurse Specialist - Psych/Mental Health Medicare: Medicare Enrolled Practice Location: 7789 Nw Beacon Square Blvd, Boca Raton, FL 33487 Phone: 561-241-7977 Fax: 561-405-2087 |
 William Charles Greenberg, APRN Clinical Nurse Specialist - Psych/Mental Health, Adult Medicare: Not Enrolled in Medicare Practice Location: 7301a W Palmetto Park Rd, Suite 106-c, Boca Raton, FL 33433 Phone: 561-391-4669 Fax: 561-391-1815 |
News Archive
GlaxoSmithKline may see increased sales of Relenza during the A/H1N1 2009 pandemic
Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that during the A/H1N1 (swine flu) pandemic, GlaxoSmithKline could see its Relenza sales increase if Tamiflu-resistant strains of the virus spread. GlaxoSmithKline recently signed A/H1N1 2009 vaccine contracts with various governments for more than $3 billion and is donating supplies to less wealthy nations, ensuring that the company strikes a balance between profit and public health concerns.
Employers to reexamine health benefit strategies in response to passage of health care reform legislation
With health care reform efforts ramping up after the summer break, many of the nation's employers are focusing on the action in Congress and plan to adjust their benefit strategies based on how final legislation affects their costs, according to a survey of 433 HR and benefit executives from midsize and large organizations conducted by professional services firm Towers Perrin.
Breakthrough in sickle cell disease and thalassemia research
Researchers have identified a gene that directly affects the production of a form of hemoglobin that is instrumental in modifying the severity of the inherited blood disorders sickle cell disease and thalassemia.
Unavailability of Avastin more dangerous risk for breast cancer patients, says FAMEDS founder
Breast cancer patients and their families will rally together on Tuesday, June 28, at 7:00 am outside of the Federal Drug Administration (FDA). At issue will be the FDA's final hearing to remove the anti-cancer drug Avastin from the approved medication list for treatment of late stage breast cancer, despite the FDA approving it in 2008 for use to treat breast cancer.
› Verified 6 days ago